Ignite Creation Date:
2024-05-06 @ 3:56 PM
Last Modification Date:
2024-10-26 @ 2:00 PM
Study NCT ID:
NCT04819841
Status:
RECRUITING
Last Update Posted:
2024-02-02
First Post:
2021-03-24
Brief Title:
Gene Correction in Autologous CD34 Hematopoietic Stem Cells HbS to HbA to Treat Severe Sickle Cell Disease
Sponsor:
Kamau Therapeutics
Organization:
Kamau Therapeutics
Organization Data
Organization:
Kamau Therapeutics
Class:
INDUSTRY
Study ID:
KMAU-001-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kamau Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None